JPWO2022226584A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022226584A5
JPWO2022226584A5 JP2024508815A JP2024508815A JPWO2022226584A5 JP WO2022226584 A5 JPWO2022226584 A5 JP WO2022226584A5 JP 2024508815 A JP2024508815 A JP 2024508815A JP 2024508815 A JP2024508815 A JP 2024508815A JP WO2022226584 A5 JPWO2022226584 A5 JP WO2022226584A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
set forth
cancer
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508815A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516748A (ja
JP2024516748A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2022/050379 external-priority patent/WO2022226584A1/en
Publication of JP2024516748A publication Critical patent/JP2024516748A/ja
Publication of JPWO2022226584A5 publication Critical patent/JPWO2022226584A5/ja
Publication of JP2024516748A5 publication Critical patent/JP2024516748A5/ja
Pending legal-status Critical Current

Links

JP2024508815A 2021-04-26 2022-04-26 EGFRvIII結合タンパク質 Pending JP2024516748A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2021901226A AU2021901226A0 (en) 2021-04-26 EGFRvIII BINDING PROTEINS II
AU2021901227A AU2021901227A0 (en) 2021-04-26 EGFRvIII BINDING PROTEINS I
AU2021901227 2021-04-26
AU2021901226 2021-04-26
PCT/AU2022/050379 WO2022226584A1 (en) 2021-04-26 2022-04-26 EGFRvIII BINDING PROTEINS

Publications (3)

Publication Number Publication Date
JP2024516748A JP2024516748A (ja) 2024-04-16
JPWO2022226584A5 true JPWO2022226584A5 (https=) 2025-04-22
JP2024516748A5 JP2024516748A5 (https=) 2025-04-22

Family

ID=83846542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508815A Pending JP2024516748A (ja) 2021-04-26 2022-04-26 EGFRvIII結合タンパク質

Country Status (5)

Country Link
US (1) US20240207407A1 (https=)
EP (1) EP4330285A4 (https=)
JP (1) JP2024516748A (https=)
AU (1) AU2022267410A1 (https=)
WO (1) WO2022226584A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240005794A (ko) * 2021-05-18 2024-01-12 쑤저우 카노바 바이오파마슈티컬 컴퍼니 리미티드 항 pd-1 폴리펩티드 및 그의 용도
AU2024360934A1 (en) * 2023-10-13 2026-04-09 The General Hospital Corporation Treating glioblastoma using car-t cell therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2958943T3 (da) * 2013-02-20 2019-12-09 Univ Pennsylvania Behandling af cancer ved anvendelse af humaniseret anti-EGFRvIII kimær antigenreceptor
TWI731535B (zh) * 2014-03-21 2021-06-21 美商艾伯維有限公司 抗-egfr抗體及抗體藥物結合物
MX2017001229A (es) * 2014-07-29 2017-05-01 Pfizer Receptores de antigenos quimericos especificos de egfrviii para inmunoterapia de cancer.
WO2020172553A1 (en) * 2019-02-22 2020-08-27 Novartis Ag Combination therapies of egfrviii chimeric antigen receptors and pd-1 inhibitors
KR20210148228A (ko) * 2019-03-27 2021-12-07 내셔날 리서치 카운실 오브 캐나다 항-EGFRvIII 항체 및 그의 항원-결합 단편

Similar Documents

Publication Publication Date Title
JP2021520788A5 (https=)
JP2021000103A5 (https=)
RU2017105161A (ru) Лечение рака с использованием химерного антигенного рецептора cll-1
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JPWO2016028896A5 (https=)
CA3032581A1 (en) Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule
JP2017524367A5 (https=)
JP2017522879A5 (https=)
JP7527641B2 (ja) スイッチ分子及びスイッチャブルキメラ抗原受容体
RU2017108903A (ru) Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей
RU2017105065A (ru) Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма
JPWO2020180591A5 (https=)
IL298326A (en) Anti-her2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
US20220396635A1 (en) Trivalent binding molecules
JPWO2019200007A5 (https=)
JP2021530233A5 (https=)
JPWO2021173985A5 (https=)
JPWO2021061778A5 (https=)
US20250051443A1 (en) Anti-cd3 monoclonal antibodies and therapeutic constructs
US20240156962A1 (en) Bcma-targeted car-t cell therapy of multiple myeloma
JPWO2019245991A5 (https=)
CN118510814A (zh) 一种嵌合抗原受体及其应用
JPWO2022226584A5 (https=)
JPWO2023068382A5 (https=)
WO2023185256A1 (zh) 特异性结合cd7的抗体及其在制备嵌合抗原受体中的应用